Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M D Boyle

Showing results (31-40 of 152) with videos related to

Pageof 16
Sort By:
Molecular Immunology|August 1, 1986
Restriction in the lytic efficiency of complement of different erythrocyte targets: a re-examination of the activities of horse C8 and C9D P Yarnall, M D Boyle
Journal of the National Cancer Institute|June 1, 1979
Complement-dependent cytotoxic antitumor antibody. II. Quantitative determination of cell-bound immunoglobulin M1M D Boyle, J J Langone
Journal of Immunological Methods|January 1, 1980
A simple procedure to use whole serum as a source of either IgG- or IgM-specific antibodyM D Boyle, J J Langone
The Journal of Pediatrics|January 1, 1984
Restoration of complement function in vivo by plasma infusion in factor I (C3b inactivator) deficiencyD J Barrett, M D Boyle
Molecular Immunology|November 1, 1995
Characterization of a type II'o group A streptococcal immunoglobulin-binding proteinT D Pack, M D Boyle
Journal of Immunology (Baltimore, Md. : 1950)|April 15, 1991
The mitogenic activity of type III bacterial Ig binding proteins (protein G) for human peripheral blood lymphocytes is not related to their ability to react with human serum albumin or IgGR A Otten, M D Boyle
Molecular Immunology|June 1, 1987
Regulation of the activation of C1 in serumE L Faulmann, M D Boyle
Microbial Pathogenesis|June 20, 1998
Interaction of a group A Streptococcus within human plasma results in assembly of a surface plasminogen activator that contributes to occupancy of surface plasmin-binding structuresS S D'Costa, M D Boyle
Journal of the Reticuloendothelial Society|February 1, 1975
The destruction of tumor cells by alloimmune peritoneal cells: mechanism of action of activated macrophages in vitroM D Boyle, M G Ormerod
Cancer Research|August 1, 1979
Relationship between the intracellular cyclic adenosine 3':5'-monophosphate level of tumor cells and their sensitivity to killing by antibody and complementT N Lo, M D Boyle
Pageof 16

Showing results (31-40 of 152) with videos related to

Sort By:
Pageof 16
Molecular Immunology|August 1, 1986
Restriction in the lytic efficiency of complement of different erythrocyte targets: a re-examination of the activities of horse C8 and C9D P Yarnall, M D Boyle
Journal of the National Cancer Institute|June 1, 1979
Complement-dependent cytotoxic antitumor antibody. II. Quantitative determination of cell-bound immunoglobulin M1M D Boyle, J J Langone
Journal of Immunological Methods|January 1, 1980
A simple procedure to use whole serum as a source of either IgG- or IgM-specific antibodyM D Boyle, J J Langone
The Journal of Pediatrics|January 1, 1984
Restoration of complement function in vivo by plasma infusion in factor I (C3b inactivator) deficiencyD J Barrett, M D Boyle
Molecular Immunology|November 1, 1995
Characterization of a type II'o group A streptococcal immunoglobulin-binding proteinT D Pack, M D Boyle
Journal of Immunology (Baltimore, Md. : 1950)|April 15, 1991
The mitogenic activity of type III bacterial Ig binding proteins (protein G) for human peripheral blood lymphocytes is not related to their ability to react with human serum albumin or IgGR A Otten, M D Boyle
Molecular Immunology|June 1, 1987
Regulation of the activation of C1 in serumE L Faulmann, M D Boyle
Microbial Pathogenesis|June 20, 1998
Interaction of a group A Streptococcus within human plasma results in assembly of a surface plasminogen activator that contributes to occupancy of surface plasmin-binding structuresS S D'Costa, M D Boyle
Journal of the Reticuloendothelial Society|February 1, 1975
The destruction of tumor cells by alloimmune peritoneal cells: mechanism of action of activated macrophages in vitroM D Boyle, M G Ormerod
Cancer Research|August 1, 1979
Relationship between the intracellular cyclic adenosine 3':5'-monophosphate level of tumor cells and their sensitivity to killing by antibody and complementT N Lo, M D Boyle
Pageof 16